Skip to main content
SpringerLink
Log in

Prognostic role of platelet to lymphocyte and lymphocyte to monocyte ratios in advanced melanoma treated with antiprogrammed death-1

  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil–to–lymphocyte ratio in solid tumors: a systematic review and meta–analysis. J Natl Cancer Inst 2014; 106: dju124.

    Article  CAS  PubMed  Google Scholar 

  2. Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta–analysis. Cancer Epidemiol Biomarkers Prev 2014; 23: 1204–12.

    Article  CAS  PubMed  Google Scholar 

  3. Fujisawa Y, Yoshino K, Otsuka A, et al. Baseline neutrophil to lymphocyte ratio combined with serum LDH level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population. Br J Dermatol 2018; 179: 213–5.

    Article  CAS  PubMed  Google Scholar 

  4. Nakamura Y, Kitano S, Takahashi A, et al. Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy. Oncotarget 2016; 7: 77404–15.

    PubMed  PubMed Central  Google Scholar 

  5. Chasseuil E, Saint–Jean M, Chasseuil H, et al. Blood predictive biomarkers for nivolumab in advanced melanoma. Acta Derm Venereol 2018; 98: 406–10.

    Article  CAS  PubMed  Google Scholar 

  6. Garnier M, Zaragoza J, Bénéton N, et al. High neutrophil–tolymphocyte ratio before starting anti–PD1 immunotherapy predicts poor outcome in patients with metastatic melanoma. J Am Acad Dermatol 2018; 79: 165–7.

    Article  PubMed  Google Scholar 

  7. Minowa T, Kato J, Hida T, et al. Prognostic role of neutrophil to lymphocyte ratio in advanced melanoma treated with anti–programmed death–1 therapy. J Dermatol 2018; 45: e250–1.

    Article  Google Scholar 

  8. Khoja L, Atenafu EG, Templeton A, et al. The full blood count as a biomarker of outcome and toxicity in ipilimumab–treated cutaneous metastatic melanoma. Cancer Med 2016; 5: 2792–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Failing JJ, Yan Y, Porrata LF, Markovic SN. Lymphocyte–to–monocyte ratio is associated with survival in pembrolizumab–treated metastatic melanoma patients. Melanoma Res 2017; 27: 596–600.

    Article  CAS  PubMed  Google Scholar 

  10. Zaragoza J, Caille A, Beneton N, et al. High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma. Br J Dermatol 2016; 174: 146–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan

    Tomoyuki Minowa, Junji Kato, Tokimasa Hida, Kohei Horimoto, Sayuri Sato, Masahide Sawada & Hisashi Uhara

Authors
  1. Tomoyuki Minowa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Junji Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tokimasa Hida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kohei Horimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sayuri Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masahide Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hisashi Uhara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomoyuki Minowa.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Minowa, T., Kato, J., Hida, T. et al. Prognostic role of platelet to lymphocyte and lymphocyte to monocyte ratios in advanced melanoma treated with antiprogrammed death-1. Eur J Dermatol 28, 705–707 (2018). https://doi.org/10.1684/ejd.2018.3381

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3381

Search

Navigation